October 31, 2025 16:05 ET | Source: Clover Health Investments, Corp. WILMINGTON, Del., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Clover…
TORONTO, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics…
October 31, 2025 16:30 ET | Source: FibroBiologics, Inc. Advancing preparations to begin manufacturing of fibroblast-based spheroids product candidate, CYWC628,…
NEW YORK, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company…
COPENHAGEN, Denmark, October 31, 2025 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered…
KUALA LUMPUR, Malaysia and NEWARK, Del., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Alps Group Inc (the “Company” or “Alps Group”),…
October 31, 2025 08:00 ET | Source: HOOKIPA Pharma Inc. NEW YORK and VIENNA, Oct. 31, 2025 (GLOBE NEWSWIRE) --…
NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Resuscitec GmbH today announced that its CARL® ECPR system has won the…
CLEVELAND, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a commercial-stage biopharmaceutical company developing cell and gene…
MOORESVILLE, N.C., Oct. 30, 2025 (GLOBE NEWSWIRE) -- The Hemp Doctor, a leader in offering premium hemp-derived products, has expanded…